Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 27, 2016
Pharmacy Choice - News - Over-the-Counter Drugs - August 27, 2016

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 28     Next >>     Go To Page:

8/26/16 - ACETO CORP - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
We are reporting net sales of $558,524 for the year ended June 30, 2016, which represents a 2.1% increase from the $546,951 reported in the comparable prior year. Gross profit for the year ended June 30, 2016 was $142,785 and our gross margin was 25.6% as compared to gross profit of $135,434 and gross margin of 24.8% in the comparable prior year.
8/26/16 - EDITORIAL: Life-saving drug? Investigate prices [The Santa Fe New Mexican]
This medicine comes out in potentially life-threatening situations, when an allergic reaction or bee sting is sending the body into anaphylactic shock. That's why it is particularly galling that the price of the pens is soaring for no apparent reason up from about $47 for a single pen in 2007 to $284 this summer. Oh, and a consumer can no longe
8/26/16 - FDAnews Announces OTC Labeling and Advertising: Claims, Compliance and Avoiding Enforcement Action Webinar, Sept. 14, 2016 [FARS News Agency]
What are the chances that the FDA will introduce user fees for OTC monograph drugs in the next six months? What lines has the FDA drawn between drugs and cosmetics that directly impact the approval and labeling of OTC products? Realize why OTC manufacturers must pay as much attention to FTC enforcement and marketing and promotion rules as they do t
8/26/16 - Global over-the-Counter Drug Market 2016-2020; New Report Launched
DrugPipeline.net has announced the addition of Global Over-the-Counter Drug Market 2016-2020 research report to their website DrugPipeline.netBangalore, India 08/26/2016 OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. The market i
8/25/16 - Blumenthal Responds to Mylan's "Baby Step" to Cut Epipen Costs & Calls for Real and Robust Action
-U.S. Senator Richard Blumenthal released the following statement today after Mylan, the manufacturer of the EpiPen Auto-Injector, announced plans to expand the company's "savings card" program, rather than reduce prices for its life-saving drug. He has called for an investigation by the Federal Trade Commission, and hearings by the Senate Judiciar
8/25/16 - BLUMENTHAL RESPONDS TO MYLAN'S 'BABY STEP' TO CUT EPIPEN COSTS & CALLS FOR REAL AND ROBUST ACTION
BLUMENTHAL RESPONDS TO MYLAN'S' BABY STEP' TO CUT EPIPEN COSTS& CALLS FOR REAL AND ROBUST ACTION. -U.S. Senator Richard Blumenthal released the following statement today after Mylan, the manufacturer of the EpiPen Auto-Injector, announced plans to expand the company's "savings card" program, rather than reduce prices for its life-saving drug.
8/25/16 - Drug Makers Stocks under Review Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline
Stock-Callers.com has initiated research reports on the following Major Drug Manufacturers in the Healthcare sector: Bristol-Myers Squibb Co., AstraZeneca PLC, Eli Lilly and Co., and GlaxoSmithKline PLC. At the close on Wednesday, shares in New York headquartered Bristol-Myers Squibb Co. saw a decline of 2.12%, ending the day at $58.59.
8/25/16 - FDAnews Announces OTC Labeling and Advertising: Claims, Compliance and Avoiding Enforcement Action Webinar, Sept. 14, 2016
What are the chances that the FDA will introduce user fees for OTC monograph drugs in the next six months? Comply with updated OTC mongographs on antiseptics, sunscreen, and cough and cold products Realize why OTC manufacturers must pay as much attention to FTC enforcement and marketing and promotion rules as they do to FDA regulation. Learn cost-s
8/25/16 - Global Animal Medication Industry
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 113 companies including many key and niche players such as- Bayer HealthCare AG Boehringer Ingelheim GmbH Ceva Sant Animale S.A Dechra Pharmaceuticals PLC Eli Lilly and Company Download the fu
8/25/16 - SECFilings.com: Bayer's ClariSpray Success Bodes Well for Innovus Pharmaceuticals' FlutiCare
SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, recently published an article highlighting the potential FDA approval of Innovus Pharmaceuticals' FlutiCare? in the nasal allergy market following the recent approval of Bayer AG's ClariSpray?. Currently, FlutiCare?' s flutica
8/25/16 - Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases
Chuck Grassley, Patrick Leahy, Amy Klobuchar, Richard Blumenthal and Ron Johnson today asked the Food and Drug Administration to answer questions about its approval process and other steps for alternatives to the EpiPen, a self-injectable remedy for severe allergic reactions that has been the subject of steep price increases from Mylan, its manufac
8/24/16 - BioPharmX Enrolls First Subject in OPAL Phase 2b Clinical Trial of BPX-01 Topical Minocycline for the Treatment of Acne
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, today announced that the first subject has been enrolled in its Phase 2 b clinical trial assessing the efficacy and safety of BPX-01 for the treatment of acne vulgaris. The study is formally known as the OPAL study. "We are optimistic the OP
8/24/16 - Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion Among 13 Daiichi Sankyo Clinical Presentations at ESC Congress 2016
Daiichi Sankyo, Inc. today announced the presentation of 13 abstracts at the ESC Congress 2016, taking place from August 27-31 in Rome, Italy. The first results from ENSURE-AF, the largest prospective randomized clinical trial to date evaluating a non-vitamin K antagonist oral anticoagulant compared to a current standard of care in patients with.
8/24/16 - EpiPen; senators seek FDA answers about any alternative products amid cost increases
Chuck Grassley, Patrick Leahy, Amy Klobuchar, Richard Blumenthal and Ron Johnson today asked the Food and Drug Administration to answer questions about its approval process and other steps for alternatives to the EpiPen, a self-injectable remedy for severe allergic reactions that has been the subject of steep price increases from Mylan, its manufac
8/24/16 - KLOBUCHAR, BIPARTISAN GROUP OF SENATORS ASK FDA TO ACCOUNT FOR ANY ALTERNATIVES TO THE EPIPEN AMID PRODUCT COST INCREASES
Klobuchar has also called for a Senate Judiciary Committee hearing and a Federal Trade Commission investigation of Mylan Pharmaceuticals for possible antitrust violations in light of the dramatic price increase of EpiPen packs. WASHINGTON, DC- Today, U.S. Senator Amy Klobuchar and a bipartisan group of senators asked the Food and Drug Administratio
8/24/16 - Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso Gel
Release date- 23082016- DUBLIN- Perrigo Company plc today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Suprep oral solution. Perrigo today also announced that it was sued by Galderma Laboratories, L.P. and Nestle Skin Health S.A. over the Company's Paragraph IV ANDA filing for th
8/24/16 - Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases
Chuck Grassley, Patrick Leahy, Amy Klobuchar, Richard Blumenthal and Ron Johnson today asked the Food and Drug Administration to answer questions about its approval process and other steps for alternatives to the EpiPen, a self-injectable remedy for severe allergic reactions that has been the subject of steep price increases from Mylan, its manufac
8/23/16 - Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso Gel
Perrigo Company plc today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Suprep oral solution. Perrigo's CEO John T. Hendrickson stated, "These accomplishments demonstrate Perrigo's commitment to our customers and consumers around the world. About Perrigo Perrigo Company plc,
8/23/16 - Woodfield Distribution Selects TraceLink to Comply With DSCSA Serialization
TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that Woodfield Distribution, LLC, a pharmaceutical third party logistics provider, has selected TraceLink's serialization solutions to comply with the..
8/22/16 - BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four Weeks
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, today released final findings from its Phase 2 a safety study of BPX-01 that show the unique topical gel formulation of minocycline reduced facial P. acnes by more than 90 percent after four weeks a statistically significant advantage over
8/22/16 - BioStem Technologies, Inc. (OTC Pink: BSEM) Acquires Their First FDA Approved Branded Generic Drug (ANDA) Granisol(R) Oral Solution
BioStem Technologies, Inc., announced today that it has acquired its first FDA approved branded generic drug, Granisol Oral Solution, an effective medicine for preventing nausea and vomiting associated with cancer chemotherapy and radiation treatments. Henry Van Vurst, CEO of BioStem Technologies, commented, "As a surviving cancer patient myself
8/22/16 - Cleobrothers & Company, Inc. and PGC Solutions, Ltd. Form Joint Venture to Distribute, Market and Promote Cleobrothers Medication Products in...
By a News Reporter-Staff News Editor at Clinical Trials Week Cleobrothers& Co., Inc. announced that it signed a joint venture agreement with PGC Solutions, Ltd. to distribute, market and promote Cleobrothers branded products in Nigeria. "PGC Solutions is the ideal sales and marketing partner," says Innocent Nweze, CEO of Cleobrothers& Co., Inc.
8/22/16 - FDA Consumer Health Information: Contact Lens Solutions With Hydrogen Peroxide: To Avoid Injury, Follow All Instructions
SILVER SPRING, Md., Aug. 22, 2016/ PRNewswire-USNewswire/ If you wear contact lenses, the way you clean them can affect your vision and health. The U.S. Food and Drug Administration regulates contact lenses and certain contact lens care products as medical devices. "But over-the-counter products are not all the same," says Bernard P. Lepri, O.D.
8/22/16 - Global Over-the-Counter Drug Market 2016-2020 - Switching of Medications from Prescription to OTC / Counterfeit Drugs / Accelerated Use of Online Resources - Research and Markets
Research and Markets has announced the addition of the "Global Over-the-Counter Drug Market 2016-2020" report to their offering. The analysts forecast the global over-the-counter drug market to grow at a CAGR of 6.19% during the period 2016-2020.. OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA con
8/22/16 - Global Over-the-Counter Drug Market 2016-2020 with Bayer HealthCare,GSK, Johnson & Johnson, Pfizer & Sanofi Dominating - Research and Markets
Research and Markets has announced the addition of the "Global Over-the-Counter Drug Market 2016-2020" report to their offering. The analysts forecast the global over-the-counter drug market to grow at a CAGR of 6.19% during the period 2016-2020.. OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA con
Articles(s): 1 - 25 of 28     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415